MedPath
FDA Approval

gadobutrol

April 17, 2025

HUMAN PRESCRIPTION DRUG LABEL

Gadobutrol(604.72 mg in 1 mL)

Registrants (1)

Slate Run Pharmaceuticals, LLC

039452765

Manufacturing Establishments (1)

Hainan Poly Pharm. Co., Ltd.

Slate Run Pharmaceuticals, LLC

Slate Run Pharmaceuticals, LLC

654561638

Products (2)

gadobutrol

70436-216

ANDA217480

ANDA (C73584)

INTRAVENOUS

April 17, 2025

CALCOBUTROL SODIUMInactive
Code: PO5286589KClass: IACT
TROMETHAMINEInactive
Code: 023C2WHX2VClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 1BJ477IO2LClass: ACTIBQuantity: 604.72 mg in 1 mL

gadobutrol

70436-217

ANDA217480

ANDA (C73584)

INTRAVENOUS

April 17, 2025

CALCOBUTROL SODIUMInactive
Code: PO5286589KClass: IACT
TROMETHAMINEInactive
Code: 023C2WHX2VClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 1BJ477IO2LClass: ACTIBQuantity: 604.72 mg in 1 mL

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


RECENT MAJOR CHANGES SECTION


DESCRIPTION SECTION

CLINICAL PHARMACOLOGY SECTION


INDICATIONS & USAGE SECTION

DOSAGE & ADMINISTRATION SECTION

DOSAGE FORMS & STRENGTHS SECTION


CONTRAINDICATIONS SECTION

BOXED WARNING SECTION

WARNINGS AND PRECAUTIONS SECTION


USE IN SPECIFIC POPULATIONS SECTION


ADVERSE REACTIONS SECTION

CLINICAL STUDIES SECTION


OVERDOSAGE SECTION


NONCLINICAL TOXICOLOGY SECTION


INFORMATION FOR PATIENTS SECTION

SPL MEDGUIDE SECTION


HOW SUPPLIED SECTION


© Copyright 2025. All Rights Reserved by MedPath